Great results, those charts are excellent.
6 patients had the 400mg dose (excluding the two that crossed from 400 to 200 or 100) and of the 6 only 2 had progressive disease at any stage, 2 are still on the drug, and 2 withdrew due to non PD reasons.
Ann: AACR Conference Presentation, page-4
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.002(2.48%) |
Mkt cap ! $16.43M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.9¢ | $839 | 14.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 130435 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 124727 | 2 |
View Market Depth
| Last trade - 10.00am 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
-0.002 ( 1.64 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.0¢ | 6.0¢ | 16000 | ||
| Last updated 10.11am 17/05/2024 ? | |||||
| ATX (ASX) Chart |